PharmaNet Faces Shareholders' Suit Over Practices That Made Stock Dive
PharmaNet, a Princeton, N.J., clinical drug development company once under U.S. Senate investigation for its treatment of human test subjects, now faces an avalanche of shareholder litigation. A putative class-action suit in federal court in Newark, N.J., alleges the company and its top executives made false and misleading statements to investors, engaged in improper business practices and tried to cover them up.Keyword Ads, Trademark Infringement, and the Lanham Act
Electronic media poses new challenges for the interpretation of the Lanham Act. It presents situations where marks are used in nontraditional ways. In particular, the use of keyword advertising, where words are linked to advertisements in a web page, may stretch the limits of the Lanham Act.Apple Can Help App Developers in Patent Fight With Lodsys, Judge Rules
Michael Karr, a college student in Las Vegas, hoped to make some side income from a raunchy iPhone app called "69 Positions." What Karr didn't foresee was that the app would drag him into costly patent litigation with Lodsys Group, a prolific patent troll.Permanent Residence Strategies for the Best and Brightest
In contrast to the task faced by most immigrating workers, an elite group of foreign professionals do not have to endure the arduous process of filing labor certification applications with the Department of Labor to get permanent resident status. Although the DOL has revamped some of its processes, immigration attorney H. Ronald Klasko advises that avoiding the labor certification process is still the avenue of choice for the "best and brightest" professionals and their employers.Eight Steps Companies Can Take to Prevent Whistleblower Liability
As businesses face greater and greater economic threats and challenges, it may be tempting to cut corners or to turn a blind eye to potentially questionable practices. But the multifaceted doom that False Claims Act violations can invite is a stark deterrent. The prospect of learning about a pending whistleblower case from the Justice Department can be among a company's worst fears. Attorney John L. Sinatra Jr. offers eight simple suggestions to help avoid false claims problems.ACC Fires Off One Last Volley at SEC Over Whistleblower 'Bounty' Plan
It's an ugly fight — but at least they're offering to help! The ACC has sent a second sharply critical letter to the SEC over a proposal to pay 'bounties' to whistleblowers, this time offering suggestions for how to fix the proposed rules.Employment Perspectives in a Regulatory Investigation
The trend in corporate investigations equates cooperation with waivers of otherwise traditionally-protected privileges. But what is the price of cooperation for a corporation's employees? One obvious cost, say David R. Clouston and Christopher R. Richie, is the demise of many protections afforded to employees. Any time the specter of a regulatory or criminal investigation becomes reality, one issue that in-house counsel must face is the significance of relatively recent guidance from the Justice Department.SOX to Ease Up on Section 404, Says Cox
For the first time in years, executives across the country may be able to stop gnashing their teeth over the cost of SOX. In the coming weeks, the SEC is expected to ease some of the SOX corporate compliance rules. In a speech last week, SEC Chairman Christopher Cox vowed that his agency would "unveil significant changes to the implementation of �404 of SOX." Specifically, the changes will center on defining how deeply an audit firm needs to delve when evaluating a company's internal controls.A Copyright Enforcement Measure Becomes Law
And patent reform rears its head once again in a pre-election flurry in D.C.Trending Stories
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250